Ephedrine vs Phenylephrine - ECG Changes
NCT01243970 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 29
Last updated 2016-10-26
Summary
ECG changes during caesarean section are common. Incidence of ST depression on the ECG is up to 81% in some studies. Although this may indicate inadequate oxygen supply to the heart muscle (myocardial ischaemia) many other theories have been suggested including air entering the circulation from the placental bed, high heart rate, hormone or nervous system influences and spasm of the coronary blood supply. Perioperative ST depression often reflects an imbalance between heart muscle oxygen supply and demand. At the time of delivery, high heart rate is common and there is a further increase in the amount of blood the heart has to pump every minute due to blood coming back to the circulation from the placental bed. This increases oxygen demand and most ST changes are seen at the time of delivery or within 30 minutes. The clinical significance of these changes is much debated, and apart from a few case reports do not appear to be associated with poor heart muscle function or ischaemia (lack of oxygen supply). Management of the mother's blood pressure during caesarean section has changed greatly in recent years. Intermittent boluses of ephedrine, given when blood pressure is low, have been replaced with prevention of low blood pressure and phenylephrine has become the drug of choice. Ephedrine increases heart rate and contractility of the heart muscle and is likely to increase oxygen demand. Phenylephrine reduces heart rate while maintaining blood pressure which may result in a more favorable oxygen supply demand ratio.
The investigators aim to compare the incidence of ECG changes if the mother's blood pressure is maintained with phenylephrine as compared to ephedrine. To see if these ECG changes are associated with myocardial ischaemia, the investigators will perform troponin T analysis after delivery. Troponin T is a molecule released by ischaemic heart muscle.
Conditions
- Spinal Anesthesia
- Pregnancy
Interventions
- DRUG
-
Phenylephrine
Infusion dose 50 mcg / minute. On/off regimen in response to blood pressure (BP) readings every minute. Approximative 30 minutes treatment duration. Total dose 50 mcg - 1500 mcg \* \* We will start the infusion after the spinal anaesthetic (see trial design), and while we will monitor cardiac output and BP (for 20 minutes) the surgeons will prep the patient (surgery not started yet). Birth should occur more or less 10-15 minutes after beginning surgery, so this is approximatively 30 minutes after spinal anaesthetic. It is very unlikely that the infusion will run continuously and exceed 1500 mcg.
- DRUG
-
Ephedrine
Infusion dose 4mg / minute. On/off regimen in response to blood pressure readings every minute. Approximative 30 minutes treatment duration. Total dose 4 mg - 120 mg. \* \* We will start the infusion after the spinal anaesthetic(see trial design), and while we will monitor cardiac output and BP (for 20 minutes) the surgeons will prep the patient (surgery not started yet). Birth should occur more or less 10-15 minutes after beginning surgery, so this is approximatively 30 minutes after spinal anaesthetic. It is very unlikely that the infusion will run continuously and exceed 120mg.
Sponsors & Collaborators
-
Obstetric Anaesthetists' Association United Kingdom
collaborator OTHER -
University College London Hospitals
lead OTHER
Principal Investigators
-
Roshan Fernando, FRCA · University College London Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-04-30
- Primary Completion
- 2016-01-31
- Completion
- 2016-01-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Maternal Haemodynamic Changes After Crystalloid Co-loading and Phenylephrine Versus Phenylephrine Alone During Spinal Anaesthesia for Elective Caesarean Delivery
NCT04026685 ·Status: COMPLETED ·Phase: NA
-
Phenylephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia
NCT04576663 ·Status: UNKNOWN ·Phase: NA
-
Ephedrine Doses to Prevent Maternal Hypotension After Spinal Anesthesia in Cesarean Section
NCT06668337 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Norepinephrine and Ephedrine on Hypotension After Spinal Anesthesia in Parturients
NCT02542748 ·Status: COMPLETED ·Phase: NA
-
The Oxygenation of the Brain During Caesarean Section
NCT01509521 ·Status: COMPLETED ·Phase: PHASE4
-
Phenylephrine in Spinal Anesthesia in Preeclamptic Patients
NCT00458003 ·Status: COMPLETED ·Phase: NA
-
Ephedrine, Phenylephrine and Metaraminol Effects on Maternal Cardiac Output, Uterine Blood Flow and Fetal Circulation
NCT02245191 ·Status: UNKNOWN ·Phase: NA
-
Effect of Ephedrine, Phenylepinephrine, and Norepinephrine on Myometrial Contractility in Pregnant People With Type II and Gestational Diabetes During Cesarean Section: An In-vitro Study
NCT06285396 ·Status: RECRUITING ·Phase: NA
-
Up-Down Determination of the ED90 of Phenylephrine for Hypotension Prophylaxis in Cesarean Delivery
NCT00796328 ·Status: TERMINATED ·Phase: PHASE4
-
Hemodynamics During Cesarean Delivery Under Spinal Anesthesia With Norepinephrine Versus Ephedrine
NCT07322419 ·Status: RECRUITING ·Phase: PHASE4
-
Effect of Ephedrine vs. Norepinephrine on Prevention of Fetal Acidosis During Cesarean Section Under Spinal Anesthesia
NCT06921473 ·Status: COMPLETED ·Phase: PHASE4
-
Maternal Cardiac Output Response to Rescue Norepinephrine and Phenylephrine Boluses in Patients With Severe Preeclampsia
NCT05035485 ·Status: COMPLETED ·Phase: NA
-
Ephedrine vs. Nor Epinephrine Infusion in Preventing Hypotension After Spinal Anesthesia for Cesarean Section
NCT02477501 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of Intermittent Intravenous Boluses of Phenylephrine and Norepinephrine to Prevent Spinal-induced Hypotension in Cesarean Deliveries
NCT02962986 ·Status: COMPLETED ·Phase: NA
-
Prophylactic Perioperative Infusion of Ephedrine Versus Noradrenaline in Patients Undergoing Cesarean Delivery Under Spinal Anesthesia
NCT07067944 ·Status: COMPLETED ·Phase: NA
-
Norepinephrine vs. Phenylephrine for Spinal Hypotension in Cesarean Section
NCT07153601 ·Status: COMPLETED ·Phase: NA
-
Prophylactic Phenylephrine Co-administration During Caesarean Section
NCT04005664 ·Status: COMPLETED ·Phase: NA
-
The Potency of Prophylactic Norepinephrine and Phenylephrine Boluses for Postspinal Anesthesia Hypotension
NCT05035472 ·Status: UNKNOWN ·Phase: NA
-
Effects of Norepinephrine-ephedrine Combination on Maternal Hemodynamics
NCT03672071 ·Status: UNKNOWN ·Phase: NA
-
Manging Post Spinal Hypotension During Elective Cesarean Section
NCT03704909 ·Status: COMPLETED ·Phase: PHASE4
-
90% Effective Dose of Phenylephrine Infusions Under Intensive and Standard Treatment in Preeclamptic Patients
NCT06151470 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Best Regimen for Phenylephrine Administration During Cesarean Section
NCT00996190 ·Status: COMPLETED ·Phase: PHASE4
-
Ideal Dose of Phenylephrine to Treat Low Blood Pressure During Cesarean Section
NCT00379691 ·Status: COMPLETED ·Phase: NA
-
Phenylephrine and Hypotension During Spinal Anesthesia for Cesarean Section
NCT02958215 ·Status: COMPLETED ·Phase: PHASE2
-
Norepinephrine Versus Ephedrine in Treatment of Hypotension During Spinal Anesthesia for Caesarean Section
NCT03163407 ·Status: COMPLETED ·Phase: NA